Clinical Trials Browser

Phase 2 × Completed × Frailty × Clear all

NCT04134390 2024-01-09

CABOMAYOR

Phase 2 Completed

Frailty, Carcinoma, Renal Cell

NCT02819011 2020-02-27

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Phase 2 Completed

44 enrolled 16 charts

Frailty, Arthritis, Diabetes Mellitus, Neoplasms, Parkinson Disease, Peripheral Arterial Disease